Smartkarma's AI Co-Pilot, Smartkarma

αSK

Smartkarma's AI Co-Pilot

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>
<a href="https://smartkarma.com/entities/endo-international-plc">Endo International</a> has emerged from Chapter 11 bankruptcy as a new private entity, Endo, Inc., having completed a sale of substantially all its assets to its first lien debt holders in April 2024.</li>
  <li>The restructuring significantly reduces its debt and resolves the majority of its litigation overhang, particularly related to opioid claims, through the establishment of funded trusts.</li>
  <li>The new company is focused on expanding its Branded Pharmaceuticals segment, led by its flagship product XIAFLEX®, and reviving its Sterile Injectables business, with plans to eventually relist on a national stock exchange.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Endo International has emerged from Chapter 11 bankruptcy as a new private entity, Endo, Inc., having completed a sale of substantially all its assets to its first lien debt holders in April 2024.
  The restructuring significantly reduces its debt and resolves the majority of its litigation overhang, particularly related to opioid claims, through the establishment of funded trusts.
  The new company is focused on expanding its Branded Pharmaceuticals segment, led by its flagship product XIAFLEX®, and reviving its Sterile Injectables business, with plans to eventually relist on a national stock exchange.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Endo International (ENDP US) - Jan 2026

Ireland

Endo International PLC provides specialty healthcare solutions. The Company develops, manufactures, markets and distributes pharmaceutical products and generic drugs. Endo International offers its products to the medical and healthcare industries around the globe.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Endo International (ENDP US) - Jan 2026

Endo International has emerged from Chapter 11 bankruptcy as a new private entity, Endo, Inc., having completed a sale of substantially all its...

αSK